Embecta Corp. (EMBC)

Market Cap	807.83M
Revenue (ttm)	1.12B
Net Income (ttm)	69.70M
Shares Out	57.70M
EPS (ttm)	1.20
PE Ratio	11.33
Forward PE	6.51
Dividend	$0.60 (4.25%)
Ex-Dividend Date	Aug 27, 2024

Volume	224,104
Open	13.67
Previous Close	13.61
Day's Range	13.67 - 14.20
52-Week Range	9.93 - 19.79
Beta	0.94
Analysts	Sell
Price Target	12.00 (-14.29%)
Earnings Date	Nov 26, 2024

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1924
• Employees: 2,200
• Stock Exchange: NASDAQ
• Ticker Symbol: EMBC
• Website: https://www.embecta.com

Financial Performance

In 2023, Embecta's revenue was $1.12 billion, a decrease of -0.77% compared to the previous year's $1.13 billion. Earnings were $70.40 million, a decrease of -68.52%.

Analyst Forecast

According to one analyst, the rating for EMBC stock is "Sell" and the 12-month stock price forecast is $12.0.

Price Target

$12.0

(-14.29% downside)

Analyst Consensus: Sell